Give a monthly donation to help us stay one step ahead of cancer with new smarter and targeted treatments – so that more people will survive blood cancer. Cecelia Brunott (pictured above) was ...

News from ASCO 2025. From 30 May to 3 June, the world’s leading oncologists and researchers, including scientists from The Institute of Cancer Research, London, will converge at the 2025 American ...

A new AI test can pick out which men with high-risk prostate cancer that has not spread will require life-extending drug abiraterone. Scientists from The Institute of Cancer Research, London, and ...

Our group has several key objectives: Mechanistically dissect the role of the MYCN oncogene, and other key oncogenic driver genes in poor-outcome paediatric solid tumours (neuroblastoma, ...

A promising new therapy can help patients with aggressive advanced breast cancer live longer and delay the need for further chemotherapy, new research has shown. The international study, funded by ...

A new AI test can pick out which men with high-risk prostate cancer that has not spread will require life-extending drug abiraterone. Scientists from The Institute of Cancer Research, London, and ...

From 30 May to 3 June, the world’s leading oncologists and researchers, including scientists from The Institute of Cancer Research, London, will converge at the 2025 American Society of Clinical ...

Karen Mawdsley’s daughter, Ellie, was diagnosed with DIPG (diffuse intrinsic pontine glioma), an aggressive brain tumour, in December 2021. She sadly passed away in July 2023, aged 23. Ellie was ...

Karen Mawdsley’s daughter, Ellie, was diagnosed with DIPG (diffuse intrinsic pontine glioma), an aggressive brain tumour, in December 2021. She sadly passed away in July 2023, aged 23. Ellie was ...

A new study suggests that silencing CXCL12, a gene involved in tissue scarring and repair, could help reduce the formation of scar tissue that can caused by radiotherapy. Ultimately, the researchers ...

Newsletter archive Search issue 51 - Spring 2025. Find out how our scientists are developing improved breast cancer tools that will help identify women at high risk and our pioneering trial to test ...